Daniel N. Swisher, Jr

Overview

Daniel N. Swisher, Jr received an average of $5M in total compensation, including $675K in salary, at Jazz Pharmaceuticals from 2018 to 2021. Daniel Swisher also received an average of $1M at Sunesis Pharmaceuticals from 2006 to 2017.

Related executives

We found 35 more executives who work or worked at Jazz Pharmaceuticals and Sunesis Pharmaceuticals.

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

Ivor Royston

Sunesis Pharmaceuticals

Chief Executive Officer

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

Chris Tovey

Jazz Pharmaceuticals

Chief Operating Officer

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

Lisa Rojkjaer

Sunesis Pharmaceuticals

Chief Medical Officer

Daniel Chevallard

Sunesis Pharmaceuticals

Chief Financial Officer

Par Hyare

Sunesis Pharmaceuticals

Chief Executive Officer

News

You may also like